Migraine Disorders: all 1,558 studies
Page 15 of 16. Open to participants first (301), then studies with results posted, then the rest; newest registration first within each.
- Sumatriptan and Naratriptan Pregnancy RegistryCompletedNCT01059604
- Rizatriptan 10 MG RPD in the Treatment of Acute MigraineCompletedNCT01057160Phase 4
- MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic UseCompletedNCT01050465Not applicable
- Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) HeadachesCompletedNCT01035983Phase 3
- Influence of a Dietary Supplement as Treatment of Migraine in Children and AdolescentsStatus unknownNCT01010711Not applicable
- The Migraine and Pain Study GeneBank at Scripps Clinic Registry (MAPS)CompletedNCT01004835
- A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.CompletedNCT00989625Phase 1
- Identification of Inflammatory Markers in Migraine PatientsStatus unknownNCT00969995
- Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting ConditionsCompletedNCT00960245Phase 1
- EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache ModelCompletedNCT00957983Phase 1/2
- A Pilot Study of Migraine and Appetite Behaviour in ChildrenCompletedNCT00930852
- Interest of Relaxation From Patients With Pain Due to MigraineCompletedNCT00904527Not applicable
- Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual MigraineCompletedNCT00904098Phase 4
- Vestibular System in Migrainous Vertigo PatientsStatus unknownNCT00901953
- Magnetic Therapy in Migraine ProphylaxisCompletedNCT00901862Phase 1
- Efficacy of Sumatriptan With Naprosyn in Migraine With AuraStatus unknownNCT00893594Not applicable
- Efficacy and Safety of BGG492 in the Treatment of MigraineCompletedNCT00892203Phase 2
- Double-blind, Placebo-controlled Study of BGC20-1531 in MigraineWithdrawnNCT00888680Phase 2
- Candesartan Versus Propranolol for Migraine PreventionCompletedNCT00884663Phase 2/3
- Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With AuraStatus unknownNCT00877838Phase 2
- An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)CompletedNCT00875784Phase 1
- fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease?CompletedNCT00868556
- Melatonin for Migraine PreventionCompletedNCT00849511Phase 2
- Treximet in Acute Migraine Headache: Assessing Cognitive FunctionStatus unknownNCT00837044Not applicable
- Randomized Trial to Evaluate the Effectiveness of a Mindfulness Based Intervention (MBSR) for Patients Suffering From MigraineCompletedNCT00826475Not applicable
- A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of MigraineCompletedNCT00821483Phase 3
- ADX10059 Migraine Prevention StudyTerminatedNCT00820105Phase 2
- Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal DefectsCompletedNCT00799045Phase 4
- Cognitive Side Effects of Commonly Prescribed Medications in Pediatric MigraineWithdrawnNCT00777218Not applicable
- Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of MigraineCompletedNCT00772473
- The Evolution and Management of Migraine Recurrence Beyond 24 HoursCompletedNCT00754611
- Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.CompletedNCT00753311Phase 4
- A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or SeparatelyCompletedNCT00752466Phase 1
- BI 44370 TA in Acute Migraine AttackCompletedNCT00751803Phase 2
- Patent Foramen Ovale in Children With Migraine HeadachesCompletedNCT00750594
- Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine AttacksCompletedNCT00743015Phase 1
- Effect of Dexamethasone on Migraine HeadacheStatus unknownNCT00733382Phase 1
- Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated DizzinessWithdrawnNCT00732108Not applicable
- Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and MigrainesCompletedNCT00727974
- Standardized sTudy With Almotriptan in eaRly Treatment of MigraineCompletedNCT00725140
- Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine PeriodCompletedNCT00723983Phase 1
- Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy VolunteersCompletedNCT00720018Phase 1
- Set Point Acupuncture for Migraines Using a Digital AssistantCompletedNCT00714727Phase 1
- Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free IntervalsCompletedNCT00700128Not applicable
- The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience MigrainesCompletedNCT00690716Phase 2
- Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)CompletedNCT00687947Not applicable
- Craniosacral Therapy in Migraine: A Feasibility StudyCompletedNCT00665236Not applicable
- Intensive Meditation and Migraines: Effects on Health and Well BeingCompletedNCT00663585Not applicable
- A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual MigraineCompletedNCT00644033Phase 3
- Study on Migraine and Headache in Epileptic PatientsCompletedNCT00642564
- DP-VPA for Migraine Prophylaxis, a Pilot Efficacy StudyWithdrawnNCT00640965Phase 2
- ZAP, US. Zomig for Appropriate for Primary CareCompletedNCT00637286Phase 4
- Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory DrugsCompletedNCT00634985Phase 4
- Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan TherapyCompletedNCT00632385Phase 4
- Efficacy and Tolerability of Zolmitriptan Nasal SprayCompletedNCT00617747Phase 3
- Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in AdolescentsCompletedNCT00617695Phase 3
- Clinical Applications of High-Frequency OscillationsWithdrawnNCT00600717
- Randomized Controlled Trial of Treating Migraine With AcupunctureCompletedNCT00599586Not applicable
- Prochlorperazine vs Imitrex for Acute Migraine in the Emergency DepartmentWithdrawnNCT00573599Not applicable
- Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute MigraineCompletedNCT00567086Phase 2
- Trial on Metoclopramide and Ketoprofen in Acute Migraine of ChildhoodWithdrawnNCT00557544Phase 3
- A Study of Gastric Delay in Migraine Patients (3207-003)CompletedNCT00548353Phase 1
- Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic MigraineCompletedNCT00541736Not applicable
- Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine HeadacheCompletedNCT00534560Phase 2
- A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine AttackCompletedNCT00530517Phase 2
- PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression IllnessSuspendedNCT00529945Not applicable
- Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)CompletedNCT00521196Not applicable
- A Study to Assess an Auto-injector Being Used to Treat a Migraine AttackCompletedNCT00510419Phase 3
- Migraine Inducing Effects and Changes in Brain Haemodynamics of PGI2Status unknownNCT00510172Not applicable
- PRIMA PFO Migraine TrialTerminatedNCT00505570Phase 2
- A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual MigraineCompletedNCT00475514Phase 3
- Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine HeadacheCompletedNCT00471952Phase 3
- Inflammatory Markers in Patients With Active Migraine HeadachesCompletedNCT00471861
- Clinical Study Of Migraine EvolutionCompletedNCT00460005
- Thrombophilia and Migraine, Are They Related?CompletedNCT00457184
- Efficacy of Pregabalin in Migraine PreventionWithdrawnNCT00447369Phase 3
- The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 MonthsCompletedNCT00442221Phase 3
- To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane HeadachesCompletedNCT00434083Phase 3
- To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine HeadachesCompletedNCT00433732Phase 3
- An Italian Randomized Open-label Study of Occipital Nerve Stimulation in the Treatment of Chronic Migraine HeadacheCompletedNCT00407992Not applicable
- A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine HeadachesTerminatedNCT00391755Phase 4
- PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood FlowCompletedNCT00380263Not applicable
- STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?TerminatedNCT00369499Not applicable
- Prochlorperazine vs MetoclopramideCompletedNCT00364806Phase 4
- Functional MRI (fMRI) in CGRP Induced MigraineCompletedNCT00363532Not applicable
- American Migraine Prevention StudyStatus unknownNCT00363506Phase 4
- Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.CompletedNCT00358839Not applicable
- A Research Study To Compare Two Kinds Of Daily HeadacheCompletedNCT00335803
- PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)SuspendedNCT00335296Not applicable
- Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With MigraineCompletedNCT00334178Phase 3
- Tonabersat in the Prophylaxis of Migraine With AuraCompletedNCT00332007Phase 2
- An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine AttackCompletedNCT00330850Phase 3
- Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With DysmenorrheaCompletedNCT00329459Phase 3
- Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)CompletedNCT00329355Phase 3
- An Adaptive Design Trial Of GW274150 In The Treatment Of Acute MigraineCompletedNCT00319137Phase 2
- Efficacy of rTMS in the Treatment of Patients With MigraineStatus unknownNCT00316979Not applicable
- Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine HeadacheCompletedNCT00311662Phase 2
- Efficacy and Safety Study of Dysport® Used for Migraine ProphylaxisCompletedNCT00301665Phase 2
- A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute MigraineCompletedNCT00300924Phase 3
- A Quality of Life Study in Patients With MigrainesTerminatedNCT00298805